Featured Clinics:

Study Details
AbbVie is testing an investigational drug, which is not approved by the Food and Drug Administration (FDA) or any health authority and is not currently available on the market. The objective of this study is to compare the safety, tolerability, and pharmacokinetics (the amount of drug absorbed by the body into your blood stream and how your body handles the drug) after taking single oral doses of the study drug under fasting conditions at increasing dose levels in healthy adults.


480 S Us Highway 45
Grayslake, IL 60031

(800) 827-2778

View Study Website
Sponsored By: AbbVie
Stipend: $0 - $4300
Length of Study: 4 weeks
Research Facility: In-Patient
Gender: Both
Age: 18 - 65
Washout Period: 30 days from Completion Date to First Dosing
Health Condition: *Healthy Volunteers Studies
 
More Information: BMI 18-32

Females must be: permanently surgically sterile, or postmenopausal for 1 year.

Non-user of tobacco for at least 6 months.
Report inaccurate listing information by clicking here